此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients (ELESDUCCBM)

2022年9月27日 更新者:Centre Hospitalier Universitaire de Nīmes

Long-term Evaluation of the Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients

Continent Cutaneous Urinary Deviation (CUD), using the Mitrofanoff, Yang-Monti or Casale principle, is offered to patients with neurological diseases who are unable to perform intermittent catheterisation through the native urethra due to upper limb disability.

There is very little data in the literature examining the long-term efficacy and complications of this technique. The main objective of this study is to evaluate the effectiveness of long-term CUDs in spinal cord injury patients. The secondary objectives are to evaluate the surgical complications and the impact on the patient's quality of life.

For each patient, several data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly and any immediate or late complications. In a second stage, a questionnaire survey will be conducted by telephone.

研究概览

研究类型

观察性的

注册 (预期的)

70

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Gard
      • Nîmes、Gard、法国、30029

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

17年 及以上 (孩子、成人、年长者)

接受健康志愿者

不适用

有资格学习的性别

全部

取样方法

非概率样本

研究人群

All patients who have suffered a spinal cord injury, operated on between April 2004 and October 2017 at Nîmes University Hospital.

描述

Inclusion Criteria:

Specific inclusion criteria for the study :

  • no history of continuous cystostomy in another centre
  • a follow-up > 24 months,
  • a continent cutaneous urinary diversion for a spinal cord injury.

General inclusion criteria :

  • Patient affiliated to or beneficiary of a health insurance scheme.
  • Adult patient (≥18 years of age) and under 85 years of age.

Exclusion Criteria:

  • Criteria for non-inclusion specific to the study :
  • All urinary incontinence outside of medullary waiting period.
  • A history of continuous cystostomy in another centre.
  • A follow-up of less than 24 months,
  • a continent cutaneous urinary diversion for a neurological pathology other than spinal cord injury.

General criteria for non-inclusion :

  • Patient in a period of exclusion determined by another study.
  • Patient for whom it is impossible to give enlightened information.
  • Patient under legal protection, guardianship or curatorship.
  • Patient unable to express consent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:队列
  • 时间观点:追溯

队列和干预

团体/队列
干预/治疗
Patients operated for Continent Cutaneous Urinary Diversion, April 2004 - October 2017
The study focuses of a population of 70 patients operated between April 2004 and October 2017 au Nîmes University Hospital for Cutaneous Urinary Diversion.
For each patient, the following data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly, immediate and later complications.
A telephone survey will be conducted by means of a questionnaire in order to evaluate the patient's quality of life.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Efficacy of continent cutaneous urinary derivation: catheterisation.
大体时间:3 -16 years after their operation
The minimum frequency of urinary catheterisation in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.
3 -16 years after their operation
Efficacy of continent cutaneous urinary derivation:leakage
大体时间:3 -16 years after their operation
Absence of leakage through the cystostomy in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.
3 -16 years after their operation

次要结果测量

结果测量
措施说明
大体时间
Surgical complications and impact on the patient's quality of life: Age at start of care
大体时间:3 -16 years after their operation
The patient's age will be noted at the start of care
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: Sex
大体时间:3 -16 years after their operation
The patient's sex will be noted at the start of care
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: Body Mass Index
大体时间:3 -16 years after their operation
The patient's Body Mass Index will be noted at the start of care
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: ASA score
大体时间:3 -16 years after their operation

The ASA Physical Status Classification System is used to assess and communicate a patient's pre-anesthesia medical comorbidities. The classification system alone does not predict the perioperative risks, but used with other factors (eg, type of surgery, frailty, level of deconditioning) it can be helpful in predicting perioperative risks.

ASA I = A normal healthy patient ASA II = A patient with mild systemic disease ASA III = A patient with severe systemic disease ASA IV = A patient with severe systemic disease that is a constant threat to life ASA V = A moribund patient who is not expected to survive without the operation ASA VI = A declared brain-dead patient whose organs are being removed for donor purposes

3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: ASIA score
大体时间:3 -16 years after their operation

The ASIA (American Spinal Injury Association) assessment is the gold standard for assessing and documenting sensory and motor impairments after Spinal Cord Injury. The score ranges from A to E as follows:

A = Complete injury. No motor or sensory function is preserved in the sacral segments S4 or S5.

B = Sensory incomplete. Sensory but not motor function is preserved below the level of injury, including the sacral segments.

C = Motor incomplete. Motor function is preserved below the level of injury, and more than half of muscles tested below the level of injury have a muscle grade less than 3 (see muscle strength scores table).

D = Motor incomplete. Motor function is preserved below the level of injury and at least half of the key muscles below the neurological level have a muscle grade of 3 or more.

E = Normal. No motor or sensory deficits, but deficits existed in the past. This score will be used to evaluate the patient at the start of care.

3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: Bladder dysfunction
大体时间:3 -16 years after their operation
The type of bladder dysfunction will be evaluated by urodynamic evaluation
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: urinary tract anomalies evaluated via a morphological examination.
大体时间:3 -16 years after their operation
Urinary tract anomalies will be evaluated via a morphological examination (using ultrasound and / or tomodensitometry).
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: cytometry
大体时间:3 -16 years after their operation
Urinary tract anomalies will be evaluated via cytometry
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: creatinine clearance
大体时间:3 -16 years after their operation
Urinary tract anomalies will be evaluated according to the patient's creatinine clearance
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: operative indications
大体时间:3 -16 years after their operation
The indications for the initial surgery will be recorded.
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: mictional mode
大体时间:3 -16 years after their operation
The patient's initial mictional mode will be recorded.
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: surgical set-up
大体时间:3 -16 years after their operation
The patient's surgical set-up will be recorded.
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: immediate or later complications
大体时间:3 -16 years after their operation
All immediate or later complications will be recorded.
3 -16 years after their operation

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年8月1日

初级完成 (预期的)

2023年1月1日

研究完成 (预期的)

2023年6月1日

研究注册日期

首次提交

2021年6月18日

首先提交符合 QC 标准的

2021年6月18日

首次发布 (实际的)

2021年6月23日

研究记录更新

最后更新发布 (实际的)

2022年9月28日

上次提交的符合 QC 标准的更新

2022年9月27日

最后验证

2022年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Data collection的临床试验

3
订阅